Skip to content

The effect of vitamin D-fortified milk on diabetes control

Determination of the effect of vitamin D-fortified milk on serum vitamin D, glycemic control, lipid profile, anthropometric measurements, and blood pressure in people with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015021721120N1
Enrollment
102
Registered
2015-05-10
Start date
2015-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group: vitamin D-fortified low fat milk, 1 cup per day for 9 week. Intervention 2: Control group: low fat milk, 1 cup per day for 9 week.
Treatment - Other
Intervention group: vitamin D-fortified low fat milk, 1 cup per day for 9 week
Control group: low fat milk, 1 cup per day for 9 week

Sponsors

Vice Chancellor for research of Shiraz University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:type 2 diabetes; Maximum age 75 years; without insulin therapy; without calcium and vitamin D supplementation in the last 3 months; not having liver and kidney failure; not having malabsorption of fat (fatty diarrhea); no history of CVD; Not taking medications that affect vitamin D metabolism, such as PTH, estrogen and calcitonin; lack of blood triglyceride lowering drugs; light to moderate physical activity; not having difficulty in eating 1 cup of milk per day; Willingness to cooperate. Exclusion criteria: Unwillingness to cooperate; Change the dose of glucose-lowering drugs; taking Calcium and vitamin D supplements during the study; Changes in levels of physical activity; Failure to adhere to the recommendations on diet and physical activity; Loss of more than 2 cups of milk a week; insulin therapy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: before intervention and after intervention. Method of measurement: blood test.

Secondary

MeasureTime frame
Total cholestrol. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;LDL cholestrol. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;HDL cholestrol. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;Triglyceride. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;Serum calcium. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;Serum vitamin D. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;Serum insulin. Timepoint: before intervention, afer intervention. Method of measurement: blood test.;Blood pressure. Timepoint: before intervention, 4 week after start of intervention, end of intervention. Method of measurement: mercury manometer.;Weight. Timepoint: before intervention, 4 week after start of intervention, end of intervention. Method of measurement: digital scale.;Waist circumference. Timepoint: before intervention, 4 week after start of intervention, end of intervention. Method of measurement: meter.;Hip circumference. Timepoint: before intervention, 4 week after start of intervention, end of intervention. Method of measurement: meter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Masoume Akhlaghi

Shiraz University of Medical Science

msm.akhlaghi@gmail.com+98 71 3725 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026